Skip to main content
Download PDF

Correction to: Safety and efficacy of paclitaxel plus carboplatin versus paclitaxel plus cisplatin in neoadjuvant chemoradiotherapy for patients with locally advanced esophageal carcinoma: a retrospective study

Radiation Oncology volume 18, Article number: 75 (2023) Cite this article

The Original Article was published on 30 December 2022

Radiation Oncology (2022) 17:218

https://doi.org/10.1186/s13014-022-02190-4

After publication of this article [1], the authors reported that in this article Li Jiang was incorrectly denoted as a corresponding author.

The original article [1] has been corrected.

References

  1. Jiang L, Zhu J, Chen X, Wang Y, Wu L, Wan G, et al. Safety and efficacy of paclitaxel plus carboplatin versus paclitaxel plus cisplatin in neoadjuvant chemoradiotherapy for patients with locally advanced esophageal carcinoma: a retrospective study. Radiat Oncol. 2022;17:218. https://doi.org/10.1186/s13014-022-02190-4

Download references

Author information

Authors and Affiliations

  1. School of Medicine, Department of Radiation Oncology, Radiation Oncology Key Laboratory of Sichuan Province, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Sichuan Cancer Hospital & Institute, University of Electronic Science and Technology of China, 55 South Renmin Ave, Fourth Section, Chengdu, Chengdu, Sichuan, 610041, China

    Li Jiang & Xue Chen

  2. Department of Radiation Oncology, Radiation Oncology Key Laboratory of Sichuan Province, Sichuan Cancer Center, School of Medicine, Sichuan Cancer Hospital & Institute, University of Electronic Science and Technology of China, 55 South Renmin Ave, Fourth Section, Chengdu, Sichuan, 610041, China

    Li Jiang, Jie Zhu, Xue Chen, Yi Wang, Lei Wu, Gang Wan & Qifeng Wang

  3. Department of Thoracic Surgery, Sichuan Cancer Center, School of Medicine, Sichuan Cancer Hospital & Institute, University of Electronic Science and Technology of China, Chengdu, China

    Yongtao Han, Xuefeng Leng & Lin Peng

Authors
  1. Li Jiang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jie Zhu
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Xue Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Yi Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Lei Wu
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Gang Wan
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Yongtao Han
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Xuefeng Leng
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Lin Peng
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Qifeng Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to Lin Peng or Qifeng Wang.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

The online version of the original article can be found at https://doi.org/10.1186/s13014-022-02190-4.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Jiang, L., Zhu, J., Chen, X. et al. Correction to: Safety and efficacy of paclitaxel plus carboplatin versus paclitaxel plus cisplatin in neoadjuvant chemoradiotherapy for patients with locally advanced esophageal carcinoma: a retrospective study. Radiat Oncol 18, 75 (2023). https://doi.org/10.1186/s13014-023-02245-0

Download citation

  • Published:

  • DOI: https://doi.org/10.1186/s13014-023-02245-0

Radiation Oncology

ISSN: 1748-717X

Contact us